TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
TCL Archive Excitement building toward 2015 goal, NCI director says in FY07 bypass budget request. NCI seeks $5.8 billion. December 2, 2005
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992